Announces completion of 1,5 Mio. Euro investment in continuation of its support of proven drugs using its high-compliance large-volume API capability with challenging chemistry and technology Lodi, February 3, ...
We are happy to announce that Archimica S.p.A will be exhibiting at CPhI Worldwide 2022 in Frankfurt. Our Team will attend the event from the 1st to 3rd of November ...
Hydralazine Hydrochloride is a highly effective drug use in treatment of severe hypertension and congestive heart failure. It is proven since many years mainly as second line and/or important part ...